• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FTLF

    FitLife Brands Inc.

    Subscribe to $FTLF
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for FitLife Brands Inc.

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    See more ratings

    FitLife Brands Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on FitLife Brands with a new price target

    Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

    3/17/25 8:22:47 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    ROTH MKM initiated coverage on FitLife Brands with a new price target

    ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

    9/3/24 7:48:49 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:27:11 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Pappas Shannon K.

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:26:27 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:07 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:05 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/2/25 8:01:06 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    CHIEF EXECUTIVE OFFICER Dayton Judd exercised 144,000 shares at a strike of $2.62, increasing direct ownership by 16% to 1,031,226 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/2/25 8:00:05 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Dawson Grant Robert was granted 2,144 shares, increasing direct ownership by 1% to 155,000 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    3/28/25 9:08:07 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Ordal Todd bought $4,556 worth of shares (150 units at $30.37), increasing direct ownership by 0.48% to 31,094 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    1/16/25 6:12:18 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    CHIEF EXECUTIVE OFFICER Dayton Judd exercised 6,200 shares at a strike of $0.70, increasing direct ownership by 1% to 443,613 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    1/2/25 4:30:14 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER York Jakob

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    9/3/24 4:20:03 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:07 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:05 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/2/25 8:01:06 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Ordal Todd bought $4,556 worth of shares (150 units at $30.37), increasing direct ownership by 0.48% to 31,094 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    1/16/25 6:12:18 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. Leadership Updates

    Live Leadership Updates

    View All

    FitLife Brands Announces Board Transition

    Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

    4/28/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    LifeVantage Appoints Dayton Judd to the Board of Directors

    SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

    2/15/24 4:05:00 PM ET
    $FTLF
    $LFVN
    $OPXS
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Electronic Components

    FitLife Brands Inc. SEC Filings

    View All

    FitLife Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/19/25 4:30:41 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/14/25 7:30:27 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by FitLife Brands Inc.

    10-Q - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/14/25 7:00:49 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/13/25 4:49:07 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/11/25 7:30:30 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/5/25 7:05:26 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEFA14A filed by FitLife Brands Inc.

    DEFA14A - FITLIFE BRANDS, INC. (0001374328) (Filer)

    6/24/25 5:00:20 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEF 14A filed by FitLife Brands Inc.

    DEF 14A - FITLIFE BRANDS, INC. (0001374328) (Filer)

    6/24/25 5:00:10 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEFA14A filed by FitLife Brands Inc.

    DEFA14A - FITLIFE BRANDS, INC. (0001374328) (Filer)

    6/24/25 5:00:01 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    5/15/25 8:00:17 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    FitLife Brands Announces Second Quarter 2025 Results

    OMAHA, NE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2025. Highlights for the second quarter ended June 30, 2025 include: Total revenue was $16.1 million, 5% lower than the second quarter of 2024.  Online revenue was $10.4 million, representing 65% of total revenue and down 7% compared to the second quarter of 2024.Gross margin was 42.8% compared to 44.8% during the second quarter of 2024.Net income for the second quarter of 2025 was $1.7 million compared to $2.6 million dur

    8/14/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Closes Acquisition of Irwin Naturals

    OMAHA, NE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that on August 8, 2025, it successfully closed the acquisition of substantially all of the assets of Irwin Naturals and its related affiliates ("Irwin") as previously approved by the US Bankruptcy Court for the Central District of California.  Through the asset purchase transaction under Section 363 of the US Bankruptcy Code, the Company acquired substantially all of the assets and assumed minimal liabilities of Irwin.  Total consideration for the acquisition was $42.5 million.

    8/11/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands to Acquire Irwin Naturals

    OMAHA, NE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced that it has entered into definitive documentation and received requisite approvals to acquire substantially all of the assets of Irwin Naturals and its related affiliates ("Irwin") under Section 363 of the US Bankruptcy Code (the "Transaction"). Highlights of the Transaction, which is expected to close on or about August 8, 2025, are as follows: The Transaction will approximately double the size of the Company, with consolidated revenue for the combined business anticipated to be in

    8/5/25 6:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Second Quarter Earnings Call

    OMAHA, NE, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the second quarter of fiscal 2025 on Thursday, August 14, 2025. In addition, the Company announced that it will hold an investor conference call after market close on August 14, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 759665.  International participants can dial (973) 528-0163 and provide the same code.

    8/1/25 8:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces First Quarter 2025 Results

    OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

    5/15/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces First Quarter Earnings Call

    OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

    5/5/25 3:00:00 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Board Transition

    Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

    4/28/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands to Present at Planet MicroCap Investor Conference

    OMAHA, NE, April 22, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 9:30 AM (Local Time - PST).  Dayton Judd, the Company's Chairman & CEO, and Ryan Hansen, the Company's Executive Vice President, will be hosting the presentation and answering questions at the conclusion. Investors can access the live presentation using the following information: Date: Wednesday, April 23, 2025Time: 9:30 AM (Las Vegas, NV Local Time PST)Webcast: https://event.summitcast.com/view/YNz6mnmEsXyrdRxb78w2nX/dWdauWRz32S

    4/22/25 7:29:59 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

    Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

    3/27/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces its Participation at the 37th Annual Roth Conference and Provides Financial and Operational Update

    Omaha, NE, March 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the 37th Annual Roth Conference on Monday and Tuesday, March 17-18, 2025.  Investors who are interested in meeting with FitLife management should submit their requests through their Roth representative. In conjunction with its participation in the conference, the Company has prepared an updated investor presentation which will be filed with the Securities and Exchange Commission on Form 8-K in advance of the conference.  The Company plans to repor

    3/13/25 8:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. Financials

    Live finance-specific insights

    View All

    FitLife Brands Announces Second Quarter 2025 Results

    OMAHA, NE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2025. Highlights for the second quarter ended June 30, 2025 include: Total revenue was $16.1 million, 5% lower than the second quarter of 2024.  Online revenue was $10.4 million, representing 65% of total revenue and down 7% compared to the second quarter of 2024.Gross margin was 42.8% compared to 44.8% during the second quarter of 2024.Net income for the second quarter of 2025 was $1.7 million compared to $2.6 million dur

    8/14/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands to Acquire Irwin Naturals

    OMAHA, NE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced that it has entered into definitive documentation and received requisite approvals to acquire substantially all of the assets of Irwin Naturals and its related affiliates ("Irwin") under Section 363 of the US Bankruptcy Code (the "Transaction"). Highlights of the Transaction, which is expected to close on or about August 8, 2025, are as follows: The Transaction will approximately double the size of the Company, with consolidated revenue for the combined business anticipated to be in

    8/5/25 6:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Second Quarter Earnings Call

    OMAHA, NE, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the second quarter of fiscal 2025 on Thursday, August 14, 2025. In addition, the Company announced that it will hold an investor conference call after market close on August 14, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 759665.  International participants can dial (973) 528-0163 and provide the same code.

    8/1/25 8:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces First Quarter 2025 Results

    OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

    5/15/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces First Quarter Earnings Call

    OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

    5/5/25 3:00:00 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

    Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

    3/27/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Fourth Quarter Earnings Call

    Omaha, NE, March 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter and full year of fiscal 2024 on Thursday, March 27, 2025. In addition, the Company announced that it will hold an investor conference call after market close on March 27, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133626.  International participants can dial (973) 528-0163 and provide t

    3/7/25 9:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Responds to Investor Questions Regarding Registration Statement

    OMAHA, NE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today responds to questions from investors regarding its filing of a registration statement with the SEC. On Thursday, November 14th, 2024, the Company filed a shelf registration statement on Form S-3 with the SEC.  On its earnings call, the Company addressed the filing of the S-3.  In response to investor questions, the Company is repeating the information provided by management on the earnings call.  In his prepared remarks during the conference call, the Company's CEO, Dayton Judd, stated

    11/18/24 8:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Third Quarter 2024 Results

    Omaha, Nov. 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2024. Highlights for the third quarter ended September 30, 2024 include: Total revenue was $16.0 million, an increase of 15% compared to the third quarter of 2023.  Online sales were $10.8 million, representing 68% of total revenue and an increase of 14% compared to the third quarter of 2023.Gross margin was 43.8% compared to 41.0% during the third quarter of 2023.Net income was $2.1 million compared to $

    11/14/24 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Third Quarter Earnings Call

    OMAHA, NE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the third quarter of fiscal 2024 on Thursday, November 14, 2024. In addition, the Company announced that it will hold an investor conference call after market close on November 14, 2024 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 683771.  International participants can dial (973) 528-0163 and provide the sam

    11/6/24 11:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care